deaths from glp-1 overdoses have been skyrocketing, with poison centers seeing a nearly 1500% increase in calls related to overdose or side effects of injectable weight-loss drugs since 2019, according to US National Poison Safety and efficacy of GLP-1/FGF21

On March 18, plaintiffs filed a response urging the court to deny Novo Nordisk and Eli Lillys motions to dismiss, stating that both companies misled the public about the safety of their drugs

But methods are improving, particularly efforts to more fully account for the benefits of medications, including, for example, reduced burdens for caregivers and families as well as economic benefits for society at large

Identifying risk factors is another important aspect

Peer-reviewed medical journals serve as crucial sources in establishing causality between alleged harmful effects and particular usage, says Alex Tin, who has extensively reported on this topic

Epub 2019 Dec 5